HomeABVC • NASDAQ
add
ABVC Biopharma Inc
Previous close
$1.59
Day range
$1.40 - $1.57
Year range
$0.67 - $9.60
Market cap
15.00M USD
Avg Volume
2.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.16K | -99.63% |
Operating expense | 1.82M | -47.21% |
Net income | -3.11M | 36.04% |
Net profit margin | -143.69K | -17,300.35% |
Earnings per share | — | — |
EBITDA | -1.95M | 37.50% |
Effective tax rate | -5.56% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 139.47K | -13.41% |
Total assets | 14.49M | 51.29% |
Total liabilities | 6.36M | 0.29% |
Total equity | 8.13M | — |
Shares outstanding | 10.53M | — |
Price to book | 1.50 | — |
Return on assets | -31.55% | — |
Return on capital | -41.68% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.11M | 36.04% |
Cash from operations | -479.46K | -3.99% |
Cash from investing | 154.17K | 285.11% |
Cash from financing | 87.42K | 134.49% |
Net change in cash | -404.16K | 30.13% |
Free cash flow | -1.02M | -1,054.70% |
About
Founded
2015
Website
Employees
18